{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:06:06Z","timestamp":1792292766295,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T00:00:00Z","timestamp":1452124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s12035-015-9636-x","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T08:16:36Z","timestamp":1452154596000},"page":"450-460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Clozapine Improves Memory Impairment and Reduces A\u03b2 Level in the Tg-APPswe\/PS1dE9 Mouse Model of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"54","author":[{"given":"Yura","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Jin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Tack","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Soo","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeni","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Won","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhee","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"issue":"2","key":"9636_CR1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jalz.2012.02.001","volume":"8","author":"Alzheimer\u2019s Association","year":"2012","unstructured":"Alzheimer\u2019s Association (2012) 2012 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 8(2):131\u2013168","journal-title":"Alzheimers Dement"},{"key":"9636_CR2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1741-7015-11-82","volume":"11","author":"W Araki","year":"2013","unstructured":"Araki W (2013) Potential repurposing of oncology drugs for the treatment of Alzheimer\u2019s disease. BMC Med 11:82","journal-title":"BMC Med"},{"key":"9636_CR3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1741-7015-11-81","volume":"11","author":"CD Hayes","year":"2013","unstructured":"Hayes CD, Dey D, Palavicini JP, Wang H, Patkar KA, Minond D, Nefzi A, Lakshmana MK (2013) Striking reduction of amyloid plaque burden in an Alzheimer\u2019s mouse model after chronic administration of carmustine. BMC Med 11:81","journal-title":"BMC Med"},{"issue":"1\u20132","key":"9636_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345791","volume":"35","author":"BS Appleby","year":"2013","unstructured":"Appleby BS, Nacopoulos D, Milano N, Zhong K, Cummings JL (2013) A review: treatment of Alzheimer\u2019s disease discovered in repurposed agents. Dement Geriatr Cogn Disord 35(1\u20132):1\u201322","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"9636_CR5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s13670-013-0056-3","volume":"2","author":"LS Honig","year":"2013","unstructured":"Honig LS, Boyd CD (2013) Treatment of Alzheimer\u2019s disease: current management and experimental therapeutics. Curr Transl Geriatr Exp Gerontol Rep 2(3):174\u2013181","journal-title":"Curr Transl Geriatr Exp Gerontol Rep"},{"issue":"Suppl 13","key":"9636_CR6","first-page":"5","volume":"63","author":"CB Nemeroff","year":"2002","unstructured":"Nemeroff CB, Kinkead B, Goldstein J (2002) Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing. J Clin Psychiatry 63(Suppl 13):5\u201311","journal-title":"J Clin Psychiatry"},{"key":"9636_CR7","doi-asserted-by":"publisher","unstructured":"Zhu S, Shi R, Li V, Wang J, Zhang R, Tempier A, He J, Kong J, Wang JF, Li XM (2014) Quetiapine attenuates glial activation and proinflammatory cytokines in APP\/PS1 transgenic mice via inhibition of nuclear factor-\u03baB pathway. Int J Neuropsychopharmacol 18(3). doi: 10.1093\/ijnp\/pyu022","DOI":"10.1093\/ijnp\/pyu022"},{"issue":"4","key":"9636_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3(4):353\u2013359","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"9636_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nurt.2008.10.031","volume":"6","author":"JJ Buccafusco","year":"2009","unstructured":"Buccafusco JJ (2009) Multifunctional receptor-directed drugs for disorders of the central nervous system. Neurotherapeutics 6(1):4\u201313","journal-title":"Neurotherapeutics"},{"issue":"1","key":"9636_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","volume":"33","author":"R Le\u00f3n","year":"2013","unstructured":"Le\u00f3n R, Garcia AG, Marco-Contelles J (2013) Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer\u2019s disease. Med Res Rev 33(1):139\u2013189","journal-title":"Med Res Rev"},{"issue":"6","key":"9636_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","volume":"7","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 7(6):157\u2013165","journal-title":"Biomol Eng"},{"issue":"3","key":"9636_CR12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659\u2013661","journal-title":"FASEB J"},{"issue":"2","key":"9636_CR13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.npp.1300039","volume":"28","author":"AV Terry Jr","year":"2003","unstructured":"Terry AV Jr, Hill WD, Parikh V, Waller JL, Evans DR, Mahadik SP (2003) Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats. Neuropsychopharmacology 28(2):300\u2013309","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"9636_CR14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0010-440X(99)90134-7","volume":"40","author":"Y Barak","year":"1999","unstructured":"Barak Y, Wittenberg N, Naor S, Kutzuk D, Weizman A (1999) Clozapine in elderly psychiatric patients: tolerability, safety, and efficacy. Compr Psychiatry 40(4):320\u2013325","journal-title":"Compr Psychiatry"},{"issue":"2","key":"9636_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1041610292001017","volume":"4","author":"AF Oberholzer","year":"1992","unstructured":"Oberholzer AF, Hendriksen C, Monsch AU, Heierli B, St\u00e4helin HB (1992) Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study. Int Psychogeriatr 4(2):187\u2013195","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"9636_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11(1):47\u201360","journal-title":"J Neurosci Methods"},{"issue":"1","key":"9636_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02686115","volume":"31","author":"KI Seyb","year":"2007","unstructured":"Seyb KI, Ansar S, Li G, Bean J, Michaelis ML, Dobrowsky RT (2007) p35\/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide. J Mol Neurosci 31(1):23\u201335","journal-title":"J Mol Neurosci"},{"key":"9636_CR18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pnpbp.2014.09.002","volume":"56","author":"S Jeon","year":"2015","unstructured":"Jeon S, Kim Y, Chung IW, Kim YS (2015) Clozapine induces chloride channel-4 expression through PKA activation and modulates CDK5 expression in SH-SY5Y and U87 cells. Prog Neuropsychopharmacol Biol Psychiatry 56:168\u2013173","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"9636_CR19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","volume":"63","author":"MG Murer","year":"2001","unstructured":"Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer\u2019s disease and Parkinson\u2019s disease. Prog Neurobiol 63(1):71\u2013124","journal-title":"Prog Neurobiol"},{"issue":"2\u20133","key":"9636_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-0173(00)00030-8","volume":"33","author":"GJ Siegel","year":"2000","unstructured":"Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer\u2019s and Parkinson\u2019s disease brain. Brain Res Brain Res Rev 33(2\u20133):199\u2013227","journal-title":"Brain Res Brain Res Rev"},{"issue":"4","key":"9636_CR21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20233","volume":"56","author":"SE Counts","year":"2004","unstructured":"Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ (2004) Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer\u2019s disease. Ann Neurol 56(4):520\u2013531","journal-title":"Ann Neurol"},{"issue":"4","key":"9636_CR22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0269881112472568","volume":"27","author":"J Lally","year":"2013","unstructured":"Lally J, Gallagher A, Bainbridge E, Avalos G, Ahmed M, McDonald C (2013) Increases in triglyceride levels are associated with clinical response to clozapine treatment. J Psychopharmacol 27(4):401\u2013403","journal-title":"J Psychopharmacol"},{"issue":"2","key":"9636_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","volume":"138","author":"SJ Allen","year":"2013","unstructured":"Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 138(2):155\u2013175","journal-title":"Pharmacol Ther"},{"issue":"1","key":"9636_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-012-8173-2","volume":"14","author":"Z Cai","year":"2012","unstructured":"Cai Z, Yan LJ, Li K, Quazi SH, Zhao B (2012) Roles of AMP-activated protein kinase in Alzheimer\u2019s disease. Neuromolecular Med 14(1):1\u201314","journal-title":"Neuromolecular Med"},{"issue":"2","key":"9636_CR25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","volume":"64","author":"AE Autry","year":"2012","unstructured":"Autry AE, Monteggia LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64(2):238\u2013258","journal-title":"Pharmacol Rev"},{"issue":"9","key":"9636_CR26","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.bbadis.2014.05.025","volume":"1842","author":"I Pedr\u00f3s","year":"2014","unstructured":"Pedr\u00f3s I, Petrov D, Allgaier M, Sureda F, Barroso E, Beas-Zarate C, Auladell C, Pall\u00e0s M, V\u00e1zquez-Carrera M, Casades\u00fas G, Folch J, Camins A (2014) Early alterations in energy metabolism in the hippocampus of APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease. Biochim Biophys Acta 1842(9):1556\u20131566","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"9636_CR27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1017\/S1461145711000976","volume":"15","author":"MK Kim","year":"2012","unstructured":"Kim MK, Kim SH, Yu HS, Park HG, Kang UG, Ahn YM, Kim YS (2012) The effect of clozapine on the AMPK-ACC-CPT1 pathway in the rat frontal cortex. Int J Neuropsychopharmacol 15(7):907\u2013917","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1\u20133","key":"9636_CR28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2006.05.021","volume":"542","author":"M Didriksen","year":"2006","unstructured":"Didriksen M, Kreilgaard M, Arnt J (2006) Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment. Eur J Pharmacol 542(1\u20133):108\u2013115","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"9636_CR29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S1041610214001756","volume":"27","author":"S Pridan","year":"2015","unstructured":"Pridan S, Swartz M, Baruch Y, Tadger S, Plopski I, Barak Y (2015) Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia. Int Psychogeriatr 27(1):131\u2013134","journal-title":"Int Psychogeriatr"},{"issue":"19","key":"9636_CR30","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.lfs.2004.12.004","volume":"76","author":"CY Cheng","year":"2005","unstructured":"Cheng CY, Hong CJ, Tsai SJ (2005) Effects of subchronic clozapine administration on serum glucose, cholesterol and triglyceride levels, and body weight in male BALB\/c mice. Life Sci 76(19):2269\u20132273","journal-title":"Life Sci"},{"issue":"10","key":"9636_CR31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2010.07.002","volume":"31","author":"HN Boyda","year":"2010","unstructured":"Boyda HN, Tse L, Procyshyn RM, Honer WG, Barr AM (2010) Preclinical models of antipsychotic drug-induced metabolic side effects. Trends Pharmacol Sci 31(10):484\u2013497","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"9636_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/toxsci\/65.1.151","volume":"65","author":"RK Kuester","year":"2002","unstructured":"Kuester RK, Waalkes MP, Goering PL, Fisher BL, McCuskey RS, Sipes IG (2002) Differential hepatotoxicity induced by cadmium in Fischer 344 and Sprague\u2013Dawley rats. Toxicol Sci 65(1):151\u2013159","journal-title":"Toxicol Sci"},{"key":"9636_CR33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2014.04.010","volume":"59","author":"J Zlatkovi\u0107","year":"2014","unstructured":"Zlatkovi\u0107 J, Todorovi\u0107 N, Tomanovi\u0107 N, Bo\u0161kovi\u0107 M, Djordjevi\u0107 S, Lazarevi\u0107-Pa\u0161ti T, Bernardi RE, Djurdjevi\u0107 A, Filipovi\u0107 D (2014) Chronic administration of fluoxetine or clozapine induces oxidative stress in rat liver: a histopathological study. Eur J Pharm Sci 59:20\u201330","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"9636_CR34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.curtheres.2008.04.007","volume":"69","author":"HY Yuan","year":"2008","unstructured":"Yuan HY, Liang HX, Liang GR, Zhang GX, Li HD (2008) Effects of clozapine administration on body weight, glucose tolerance, blood glucose concentrations, plasma lipids, and insulin in male C57BL\/6 mice: a parallel controlled study. Curr Ther Res Clin Exp 69(2):142\u2013149","journal-title":"Curr Ther Res Clin Exp"},{"issue":"3","key":"9636_CR35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1176\/jnp.23.3.jnp242","volume":"23","author":"EC Lauterbach","year":"2011","unstructured":"Lauterbach EC, Mendez MF (2011) Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research. J Neuropsychiatry Clin Neurosci 23(3):242\u2013260","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"9636_CR36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nbd.2006.06.007","volume":"24","author":"BL Burgess","year":"2006","unstructured":"Burgess BL, McIsaac SA, Naus KE, Chan JY, Tansley GH, Yang J, Miao F, Ross CJ, van Eck M, Hayden MR, van Nostrand W, St George-Hyslop P, Westaway D, Wellington CL (2006) Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer\u2019s disease mouse models with abundant A beta in plasma. Neurobiol Dis 24(1):114\u2013127","journal-title":"Neurobiol Dis"},{"issue":"2","key":"9636_CR37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/acel.12185","volume":"13","author":"A Currais","year":"2014","unstructured":"Currais A, Prior M, Dargusch R, Armando A, Ehren J, Schubert D, Quehenberger O, Maher P (2014) Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer\u2019s disease transgenic mice. Aging Cell 13(2):379\u2013390","journal-title":"Aging Cell"},{"issue":"45","key":"9636_CR38","doi-asserted-by":"crossref","first-page":"11670","DOI":"10.1523\/JNEUROSCI.3321-06.2006","volume":"26","author":"A Menegon","year":"2006","unstructured":"Menegon A, Bonanomi D, Albertinazzi C, Lotti F, Ferrari G, Kao HT, Benfenati F, Baldelli P, Valtorta F (2006) Protein kinase A-mediated synapsin I phosphorylation is a central modulator of Ca2\u2009+\u2009\u2212dependent synaptic activity. J Neurosci 26(45):11670\u201311681","journal-title":"J Neurosci"},{"issue":"21","key":"9636_CR39","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1523\/JNEUROSCI.3973-13.2014","volume":"34","author":"AM Verstegen","year":"2014","unstructured":"Verstegen AM, Tagliatti E, Lignani G, Marte A, Stolero T, Atias M, Corradi A, Valtorta F, Gitler D, Onofri F, Fassio A, Benfenati F (2014) Phosphorylation of synapsin I by cyclin-dependent kinase-5 sets the ratio between the resting and recycling pools of synaptic vesicles at hippocampal synapses. J Neurosci 34(21):7266\u20137280","journal-title":"J Neurosci"},{"issue":"1","key":"9636_CR40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1096\/fj.10-167361","volume":"25","author":"V Vingtdeux","year":"2011","unstructured":"Vingtdeux V, Chandakkar P, Zhao H, d\u2019Abramo C, Davies P, Marambaud P (2011) Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-\u03b2 peptide degradation. FASEB J 25(1):219\u2013231","journal-title":"FASEB J"},{"issue":"4","key":"9636_CR41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2010.07.081","volume":"399","author":"JS Won","year":"2010","unstructured":"Won JS, Im YB, Kim J, Singh AK, Singh I (2010) Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis. Biochem Biophys Res Commun 399(4):487\u2013491","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"9636_CR42","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1093\/emboj\/cdf636","volume":"21","author":"JA Tsch\u00e4pe","year":"2002","unstructured":"Tsch\u00e4pe JA, Hammerschmied C, M\u00fchlig-Versen M, Athenstaedt K, Daum G, Kretzschmar D (2002) The neurodegeneration mutant l\u00f6chrig interferes with cholesterol homeostasis and Appl processing. EMBO J 21(23):6367\u20136376","journal-title":"EMBO J"},{"issue":"3","key":"9636_CR43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm.1912","volume":"15","author":"AH Nagahara","year":"2009","unstructured":"Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer\u2019s disease. Nat Med 15(3):331\u2013337","journal-title":"Nat Med"},{"issue":"3","key":"9636_CR44","doi-asserted-by":"crossref","first-page":"e91453","DOI":"10.1371\/journal.pone.0091453","volume":"9","author":"NA Castello","year":"2014","unstructured":"Castello NA, Nguyen MH, Tran JD, Cheng D, Green KN, LaFerla FM (2014) 7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss. PLoS One 9(3):e91453","journal-title":"PLoS One"},{"issue":"3","key":"9636_CR45","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/npp.2013.243","volume":"39","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Liu X, Schroeder JP, Chan CB, Song M, Yu SP, Weinshenker D, Ye K (2014) 7,8-Dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 39(3):638\u2013650","journal-title":"Neuropsychopharmacology"},{"key":"9636_CR46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnbeh.2015.00058","volume":"9","author":"L Psotta","year":"2015","unstructured":"Psotta L, Rockahr C, Gruss M, Kirches E, Braun K, Lessmann V, Bock J, Endres T (2015) Impact of an additional chronic BDNF reduction on learning performance in an Alzheimer mouse model. Front Behav Neurosci 9:58","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"9636_CR47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","volume":"71","author":"O Bai","year":"2003","unstructured":"Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM (2003) Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res 71(1):127\u2013131","journal-title":"J Neurosci Res"},{"issue":"3","key":"9636_CR48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jpsychires.2008.05.010","volume":"43","author":"SW Park","year":"2009","unstructured":"Park SW, Lee CH, Lee JG, Lee SJ, Kim NR, Choi SM, Kim YH (2009) Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats. J Psychiatr Res 43(3):274\u2013281","journal-title":"J Psychiatr Res"},{"issue":"1","key":"9636_CR49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajp.2012.08.010","volume":"6","author":"CD Pandya","year":"2013","unstructured":"Pandya CD, Kutiyanawalla A, Pillai A (2013) BDNF-TrkB signaling and neuroprotection in schizophrenia. Asian J Psychiatr 6(1):22\u201328","journal-title":"Asian J Psychiatr"},{"issue":"4","key":"9636_CR50","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12031-015-0500-2","volume":"56","author":"W Huang","year":"2015","unstructured":"Huang W, Cao J, Liu X, Meng F, Li M, Chen B, Zhang J (2015) AMPK plays a dual role in regulation of CREB\/BDNF pathway in mouse primary hippocampal cells. J Mol Neurosci 56(4):782\u2013788","journal-title":"J Mol Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9636-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9636-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:48:08Z","timestamp":1559443688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9636-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["9636"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9636-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,7]]}}}